XNAS · NVNO
-0.72% · -$0.0800 · Vol 1.5K
Market closed · last close 4:00 PM ET · price as of 09:30:00 ET
enVVeno Medical Corporation Common Stock

enVVeno Medical Corporation Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$11.07
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
NVNO
enVVeno Medical Corporation Common Stock
Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

69/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5/6 factors with data · Wed Aug 5 · session closed · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is NVNO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading NVNO catalysts
About enVVeno Medical Corporation Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2018
Employees
33
Country
US

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$11.07
Day high
$11.07
Day low
$11.07
Previous close
$11.15
52W high
$174.82
-93.67% from high
52W low
$8.67
1% of range
Market cap
$7.4M
EPS
$-11.8200
Beta
-0.03
Shares out
667.7K
Volume
1.5K
0.09× rel vol
Avg volume
17.2K
VWAP
$11.19
Price history computed in-house
1W
+6.44%
1M
-0.27%
3M
+8.32%
1Y
-93.52%
YTD
-1.41%
SMA 50 $10.68 · above
SMA 200 $12.58 · below
52W position 1%

NVNO overview

Loading financial statements
Loading NVNO Form 4 filings
Public disclosures

Congress activity in NVNO

No receipt-qualified Congressional disclosure is present for NVNO in the cached public ledger.

Federal contracts

NVNO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for NVNO in this window.
Lobbying spend

NVNO lobbying filings, year to date.

Registered lobbying filings matched to enVVeno Medical Corporation Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for NVNO in this window.
Loading news for NVNO
Analyst ratings
Sovereign unlock shows live analyst consensus for NVNO.
Options
Sovereign unlock shows live options positioning for NVNO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.